Try a new search

Format these results:

Searched for:

school:SOM

Department/Unit:Neurology

Total Results:

23152


A real-world study characterizing symptoms and impacts of fatigue in us adults with relapsing multiple sclerosis using a novel disease specific scale [Meeting Abstract]

Azoulai, M.; Levy-Heidmann, T.; Morisseau, V.; Jamieson, C.; Charvet, L.; Krupp, L.; Lair, L.
ISI:000596547102096
ISSN: 1352-4585
CID: 4737212

No difference in radiologic outcomes for natalizumab patients on extended interval dosing compared with standard interval dosing in ms paths [Meeting Abstract]

Zhovtis-Ryerson, L.; Naismith, R. T.; Krupp, L.; Charvet, L.; Su, R.; Fisher, E.; De Moor, C.; Williams, J.; Campbell, N.
ISI:000596547101134
ISSN: 1352-4585
CID: 4735892

Sprinting into the field of neuro-ophthalmology from the streets of Brooklyn

Galetta, Steven L
PMCID:7370262
PMID: 32695429
ISSN: 2053-8871
CID: 4532342

Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis)

Nehete, Pramod N; Williams, Lawrence E; Chitta, Sriram; Nehete, Bharti P; Patel, Akash G; Ramani, Margish D; Wisniewski, Thomas; Scholtzova, Henrieta
One means of stimulating the mammalian innate immune system is via Toll-like receptor 9 (TLR9) being exposed to unmethylated cytosine-phosphate-guanine (CpG) DNA, also known as pathogen-associated molecular patterns (PAMPs) of microbial origin. Synthetic CpG oligodeoxynucleotides (ODNs) with defined CpG motifs possess broad immunostimulatory properties that make CpG ODNs suitable as therapeutic interventions in a variety of human disease conditions, including Alzheimer's disease (AD). Rodent models are often used to preclinically test the effectiveness of CpG ODN therapeutic agents for AD and other disorders. However, the translatability of findings in such models is limited due to the significant difference of the expression of TLR9 between primates and rodents. The squirrel monkey (SQM), a New World non-human primate (NHP), is known to be phylogenetically proximate to humans, and develops extensive age-dependent cerebral amyloid angiopathy (CAA), a key pathological feature of AD. Hence, this model is currently being used to test AD therapeutics. In the present study, we conducted the first examination of Class C CpG ODN's immunomodulatory role in elderly SQMs. We documented the effectiveness of CpG ODN to trigger an immune response in an aged cohort whose immune system is senescent. The specific immune response patterns detected here closely resembled CpG ODN-induced immunostimulatory patterns observed in prior human studies. Overall, our findings provide critical data regarding the immunomodulatory potential of CpG ODN in this NHP model, allowing for future translational studies of innate immunity stimulation via TLR9 agonists for diverse indications, including AD therapeutics.
PMCID:7063459
PMID: 32194391
ISSN: 1663-4365
CID: 4353072

Correction to: Unrecognized implementation science engagement among health researchers in the USA: a national survey

Stevens, Elizabeth R; Shelley, Donna; Boden-Albala, Bernadette
[This corrects the article DOI: 10.1186/s43058-020-00027-3.].
PMID: 32885799
ISSN: 2662-2211
CID: 4940662

Unrecognized implementation science engagement among health researchers in the USA: a national survey

Stevens, Elizabeth R; Shelley, Donna; Boden-Albala, Bernadette
Background/UNASSIGNED:Implementation science (IS) has the potential to serve an important role in encouraging the successful uptake of evidence-based interventions. The current state of IS awareness and engagement among health researchers, however, is relatively unknown. Methods/UNASSIGNED:To determine IS awareness and engagement among health researchers, we performed an online survey of health researchers in the USA in 2018. Basic science researchers were excluded from the sample. Engagement in and awareness of IS were measured with multiple questionnaire items that both directly and indirectly ask about IS methods used. Unrecognized IS engagement was defined as participating in research using IS elements and not indicating IS as a research method used. We performed simple logistic regressions and tested multivariable logistic regression models of researcher characteristics as predictors of IS engagement. Results/UNASSIGNED:< 0.001). Conclusion/UNASSIGNED:Overall, awareness of IS is high among health researchers, yet there is also a high prevalence of unrecognized IS engagement. Efforts are needed to further disseminate what constitutes IS research and increase IS awareness among health researchers.
PMID: 32885196
ISSN: 2662-2211
CID: 4940652

It's Not Always An Infection: Pyoderma Gangrenosum of the Urogenital Tract in Two Patients with Multiple Sclerosis Treated with Rituximab [Meeting Abstract]

Parrotta, Erica; Ryerson, Lana Zhovtis; Krupp, Lauren
ISI:000536058003194
ISSN: 0028-3878
CID: 4561322

Lower Long-Term Disability with Early Start of High-Efficacy Therapies in Multiple Sclerosis [Meeting Abstract]

He, Anna; Merkel, Bernd; Brown, J. William; Ryerson, Lana Zhovtis; Kister, Ilya; Malpas, Charles; Horakova, Dana; Havrdova, Eva; Izquierdo Ayuso, Guillermo; Eichau Madueno, Sara; Lugaresi, Alessandra; Hupperts, R. M. M.; Sola, Patrizia; Ferraro, Diana; Butzkueven, Helmut; Grand-Maison, Francois; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Petersen, Thor; Grammond, Pierre; Granella, Franco; Van Pesch, Vincent; Bergamaschi, Roberto; Kalincik, Tomas
ISI:000536058002065
ISSN: 0028-3878
CID: 4561202

Recognition and Treatment of New Onset Focal Seizures in Emergency Departments [Meeting Abstract]

Pellinen, Jacob; Tafuro, Erica; Yang, Annie; Price, Dana; French, Jacqueline
ISI:000536058001035
ISSN: 0028-3878
CID: 4561082

COVID-19 infection in patients with multiple sclerosis: an observational study by the New York COVID-19 neuroimmunology consortium (NYCNIC) [Meeting Abstract]

Klineova, S.; Harel, A.; Farber, R. Straus; Zhang, Y.; Deangelis, T.; Leung, T. M.; Fong, K.; Smith, T.; Blanck, R.; Filomena, S.; Karran, M.; Gurgova, S.; Onomichi, K.; Zhovtis-Ryerson, L.
ISI:000596547100152
ISSN: 1352-4585
CID: 4735852